Clinical Trial Update: A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety of DA-3030 and exploring its efficacy for diabetic neuropathic pain; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• DA-3030

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Diabetic Neuropathy | Phase 1 | Status: COMPLETED